Search

everythinglearnresearchcommunity

for

Search:↓

A method was developed to test the breakdown of Finasteride capsules, showing it can tell the difference between different brands and highlighting the need for standard tests and ingredient consistency.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Tcf3 helps cells move and heal wounds by controlling lipocalin 2.

Tofacitinib helped regrow hair in a teen with a unique pattern of alopecia areata.

Bimatoprost treats glaucoma and promotes hair growth, with potential for more medical uses.

Renaming frontal fibrosing alopecia to a syndrome could improve diagnosis and treatment.

Certain gene variations in the Vitamin D Receptor are linked to higher risk of female hair loss.

SFRP2 and PTGDS may be key factors in female hair loss.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

ATP-sensitive potassium channels are important for hair growth.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Hair transplant destroyed by lichen planopilaris.

The commentary suggests that certain hair and skin care products may be linked to frontal fibrosing alopecia, but not sunscreens, and calls for more thorough research on the causes.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Trypsin slows hair growth and affects color by causing cell death in hair follicles.

Follicle Stimulating Hormone is important for fertility.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Water and fatty acids affect hair's surface differently based on hair damage, and models can help understand hair-cosmetic interactions.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Tufted folliculitis is common in patients with folliculitis decalvans.

A new microneedle patch effectively treats hair loss by delivering growth factors to the skin.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Hair loss condition FFA was seen before the appearance of skin depigmentation vitiligo in a patient.

KAP6 genes are conserved across species and active in hair follicles.

The superficial temporal artery flap is a reliable method for reconstructing complex facial defects with minimal complications.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.